JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients

Blood

Volumn 118, Issue 9, 2011, Pages 2599-2601

  Panova Noeva, Marina ^a,b   Marchetti, Marina ^a   Buoro, Sabrina ^a   Russo, Laura ^a   Leuzzi, Annamaria ^a   Finazzi, Guido ^a   Rambaldi, Alessandro ^a   Ottomano, Cosimo ^a   Ten Cate, Hugo ^b   Falanga, Anna ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYUREA; JANUS KINASE 2;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMATURE PLATELET; MAJOR CLINICAL STUDY; MALE; MUTATION; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

EID: 80052441368     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-339655     Document Type: Article

References (13)

1. Harrison P., Robinson M.S., Mackie I.J., Machin S.J. Reticulated platelets. Platelets. 1997;8(6):379-383. (Pubitemid 28031350)
2. Watanabe K., Kawai Y., Takeuchi K. Reticulated platelets-automated measurement and clinical utility. Rinsho Ketsueki. 1995;36(4):267-272.
3. Ryningen A., Apelseth T., Hausken T., Bruserud O. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Platelets. 2006;17(5):296-302. (Pubitemid 44277695)
4. Grove E.L., Hvas A.M., Kristensen S.D. Immature platelets in patients with acute coronary syndromes. Thromb Haemost. 2009;101(1):151-156.
5. Briggs C., Kunka S., Hart D., Oguni S., Machin S.J. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol. 2004;126(1):93-99. (Pubitemid 38859488)
6. Cesari F., Marcucci R., Caporale R., et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost. 2008;99(5):930-935. (Pubitemid 351705311)
7. Marchetti M., Castoldi E., Spronk H.M., et al. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood. 2008;112(10):4061-4068.
8. Robinson M.S., Mackie I.J., Khair K., et al. Flow cytometric analysis of reticulated platelets: Evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. Br J Haematol. 1998;100(2):351-357. (Pubitemid 28131070)
9. Briggs C., Hart D., Kunka S., Oguni S., Machin S.J. Immature platelet fraction measurement: A future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med. 2006;16(2):101-109. (Pubitemid 43935066)
10. Rinder H.M., Schuster J.E., Rinder C.S., Wang C., Schweidler H.J., Smith B.R. Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood. 1998;91(4):1288-1294. (Pubitemid 28086882)
11. Nakamura T., Uchiyama S., Yamazaki M., Okubo K., Takakuwa Y., Iwata M. Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. Thromb Res. 2002;106(4):171-177. (Pubitemid 35248047)
12. Cesari F., Marcucci R., Gori A.M., et al. High platelet turnover and reactivity in renal transplant recipients patients. Thromb Haemost. 2010;104(4):804-810.
13. Sirhan S., Lasho T.L., Hanson C.A., Mesa R.A., Pardanani A., Tefferi A. The presence of JAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea. Am J Hematol. 2008;83(5):363-365. (Pubitemid 351614747)